OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exosomal miR‐222‐3p contributes to castration‐resistant prostate cancer by activating mTOR signaling
Weixi Wang, Piaoping Kong, Kangle Feng, et al.
Cancer Science (2023) Vol. 114, Iss. 11, pp. 4252-4269
Open Access | Times Cited: 14
Weixi Wang, Piaoping Kong, Kangle Feng, et al.
Cancer Science (2023) Vol. 114, Iss. 11, pp. 4252-4269
Open Access | Times Cited: 14
Showing 14 citing articles:
Exosomal Liquid Biopsy in Prostate Cancer: A Systematic Review of Biomarkers for Diagnosis, Prognosis, and Treatment Response
Yameen Hamid, Rukhshana Dina Rabbani, Rakkan Afsara, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 802-802
Open Access | Times Cited: 3
Yameen Hamid, Rukhshana Dina Rabbani, Rakkan Afsara, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 802-802
Open Access | Times Cited: 3
CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3
Kun Zhong, Wenwu Luo, Nan Li, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 2
Open Access | Times Cited: 7
Kun Zhong, Wenwu Luo, Nan Li, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 2
Open Access | Times Cited: 7
Mirna Based Liquid Biopsy for Castration-Resistant Prostate Cancer Diagnostics
E.V. Shutko, Maria Konoshenko, Milena Saitkulova, et al.
(2025)
Closed Access
E.V. Shutko, Maria Konoshenko, Milena Saitkulova, et al.
(2025)
Closed Access
Comprehensive Analysis Reveals Midnolin as a Potential Prognostic, Therapeutic, and Immunological Cancer Biomarker
Xinguo Zhang, Wenting Li, Xin Jin, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 276-276
Open Access
Xinguo Zhang, Wenting Li, Xin Jin, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 276-276
Open Access
Mesenchymal stromal cell exosomes for drug delivery of prostate cancer treatments: a review
Chengran Wang, Yanling Feng, Xianfang Rong, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Chengran Wang, Yanling Feng, Xianfang Rong, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Small extracellular vesicles: crucial mediators for prostate cancer
Sijie Tang, Huiying Cheng, Xueyan Zang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Sijie Tang, Huiying Cheng, Xueyan Zang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
The influence of maximal androgen blockade and radical prostatectomy on urinary extracellular vesicle miRNA expression
E.V. Shutko, Olga E. Bryzgunova, Ilya Ostaltsev, et al.
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access
E.V. Shutko, Olga E. Bryzgunova, Ilya Ostaltsev, et al.
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access
MicroRNAs as Promising Therapeutic Agents Against Prostate Cancer Resistant to Castration—Where Are We Now?
Mariana Ferreira, Mariana Morais, Rui Medeiros, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1347-1347
Open Access | Times Cited: 3
Mariana Ferreira, Mariana Morais, Rui Medeiros, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1347-1347
Open Access | Times Cited: 3
Harnessing tumor‐derived exosomes: A promising approach for the expansion of clinical diagnosis, prognosis, and therapeutic outcome of prostate cancer
Mohammadbagher Pirouzpanah, Soraya Babaie, Samira Pourzeinali, et al.
BioFactors (2024) Vol. 50, Iss. 4, pp. 674-692
Closed Access | Times Cited: 2
Mohammadbagher Pirouzpanah, Soraya Babaie, Samira Pourzeinali, et al.
BioFactors (2024) Vol. 50, Iss. 4, pp. 674-692
Closed Access | Times Cited: 2
Deregulated miRNAs in enzalutamide resistant prostate cancer: A comprehensive review of key molecular alterations and clinical outcomes
Inês Ferreira Dias Tavares, Mariana Morais, Francisca Dias, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 2, pp. 189067-189067
Closed Access | Times Cited: 3
Inês Ferreira Dias Tavares, Mariana Morais, Francisca Dias, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 2, pp. 189067-189067
Closed Access | Times Cited: 3
Role of extracellular vesicles in castration-resistant prostate cancer
Chaoyu Liao, Zeyu Huang, Jingui Liu, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104348-104348
Closed Access
Chaoyu Liao, Zeyu Huang, Jingui Liu, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104348-104348
Closed Access
The biological function of extracellular vesicles in prostate cancer and their clinical application as diagnostic and prognostic biomarkers
Patrízia Limonta, Sara Marchesi, Gaia Giannitti, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1611-1627
Open Access
Patrízia Limonta, Sara Marchesi, Gaia Giannitti, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1611-1627
Open Access
Research Progress on the Mechanism of Androgen Receptor Signaling Pathway in Castration-Resistant Prostate Cancer
Na Cui, Mingjie Li
annals of urologic oncology (2023)
Open Access
Na Cui, Mingjie Li
annals of urologic oncology (2023)
Open Access
